Clinical trial
Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients…
NCT00437177 · Hospital Universitari Vall d'Hebron Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00437177 |
|---|---|
| Title | Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO) |
| Official title | Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence: Predictive Value for Relapse |
| Acronym | ALC-DRD2-APO |
| Lead sponsor | Hospital Universitari Vall d'Hebron Research Institute, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | apomorphine, [(123)I] iodobenzamide |
| Enrollment | 50 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Feb 19, 2007 |
| Last update posted | Apr 29, 2009 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: